IMCD NV was founded in 1995 and is headquartered in the Netherlands. The company engages in the marketing, sales, and distribution of speciality chemicals and food ingredients. Company business segments include Home Care and I&I, Pharma, Personal Care, Coating and Construction, Food and Nutrition, Lubricants and Fuels, Synthesis, Advanced Materials, and more.
The company employs over 2,700 people and serves more than 43,000 customers who use its 37,000 products. IMCD NV collaborates with about 1,900 suppliers around the world.
IMCD has a strong position in EMEA, Asia-Pasific and the Americas in several different life science and industrial end markets. In 2019, the company announced the opening of a Pharma Technical Centre in New Jersey, in the US, a new Lubricants & Fuels laboratory in Australia, and its listing on the AEX index.
In 2018, IMCD NV reported €2,379.1 million in revenue. During the first quarter of fiscal 2019, the company reported profit growth of 23% amounting to €157.9 million. Interested in trading this instrument? Follow it for news and updates on the current IMCD.NV value.